Chembio Diagnostics Inventory Turnover Ratio 2006-2019 | CEMI

Chembio Diagnostics inventory turnover ratio from 2006 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
Chembio Diagnostics Inventory Turnover Ratio Historical Data
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.074B $0.033B
CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio is licensed by the U.S. Food and Drug Administration as well as the U. S. Department of Agriculture, and is certified for the global market under the International Standards Organization directive 13.485.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $159.868B 27.90
Medtronic (MDT) Ireland $159.853B 22.08
Stryker (SYK) United States $80.144B 26.95
Boston Scientific (BSX) United States $60.227B 28.43
Baxter (BAX) United States $46.348B 28.10
Essilor Luxottica (ESLOY) France $32.970B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.400B 19.07
Lonza Group Ag (LZAGY) Switzerland $30.070B 0.00
Coloplast (CLPBY) Denmark $27.194B 41.97
Terumo (TRUMY) Japan $27.183B 0.00
ResMed (RMD) United States $23.349B 43.07
Smith & Nephew SNATS (SNN) United Kingdom $22.117B 0.00
Sunny Optical Technology (SNPTF) China $19.732B 0.00
Insulet (PODD) United States $11.904B 566.35
Bio-Rad Laboratories (BIO) United States $11.075B 53.16
Perrigo (PRGO) Ireland $7.998B 14.91
Canopy Growth (CGC) Canada $7.913B 0.00
William Demant Holdings (WILYY) Denmark $7.896B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
Hill-Rom Holdings (HRC) United States $7.341B 21.13
GN STORE NORD (GNNDY) Denmark $6.158B 0.00
Haemonetics (HAE) United States $5.446B 36.80
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.013B 31.60
ICU Medical (ICUI) United States $3.880B 25.30
Neogen (NEOG) United States $3.553B 59.13
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Quidel (QDEL) United States $3.250B 30.84
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.132B 0.00
Agios Pharmaceuticals (AGIO) United States $3.123B 0.00
National Vision Holdings (EYE) United States $2.908B 65.64
Aurora Cannabis (ACB) Canada $2.168B 0.00
Cardiovascular Systems (CSII) United States $1.807B 0.00
InMode (INMD) Israel $1.563B 0.00
AtriCure (ATRC) United States $1.486B 0.00
TG Therapeutics (TGTX) United States $1.344B 0.00
Aphria (APHA) $1.331B 0.00
VAREX IMAGING (VREX) United States $1.175B 23.49
Phibro Animal Health (PAHC) United States $1.024B 19.17
NanoString Technologies (NSTG) United States $1.005B 0.00
PetIQ (PETQ) United States $0.873B 21.30
Eagle Pharmaceuticals (EGRX) United States $0.778B 29.81
Quanterix (QTRX) United States $0.752B 0.00
LeMaitre Vascular (LMAT) United States $0.729B 40.99
Lantheus Holdings (LNTH) United States $0.708B 17.68
Omeros (OMER) United States $0.674B 0.00
Cerus (CERS) United States $0.641B 0.00
Surmodics (SRDX) United States $0.548B 56.80
MacroGenics (MGNX) United States $0.529B 0.00
OraSure Technologies (OSUR) United States $0.490B 29.41
Organigram Holdings (OGI) Canada $0.451B 0.00
Meridian Bioscience (VIVO) United States $0.408B 14.02
HEXO (HEXO) $0.401B 0.00
Owens & Minor (OMI) United States $0.394B 14.58
Utah Medical Products (UTMD) United States $0.385B 27.90
Zynex (ZYXI) United States $0.331B 37.48
BioLife Solutions (BLFS) United States $0.310B 126.17
Bovie Medical (APYX) United States $0.274B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.256B 0.00
Female Health (VERU) United States $0.243B 0.00
Vapotherm (VAPO) United States $0.241B 0.00
Repro-Med Systems (KRMD) United States $0.233B 0.00
United Health Products (UEEC) United States $0.224B 0.00
Viemed Healthcare (VMD) United States $0.209B 22.00
Liberty Health Sciences (LHSIF) Canada $0.178B 0.00
Rockwell Medical (RMTI) United States $0.164B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.164B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
Fonar (FONR) United States $0.132B 9.32
Chimerix (CMRX) United States $0.117B 0.00
MTech Acquisition (KERN) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.086B 0.00
United-Guardian (UG) United States $0.083B 20.95
MRI Interventions (MRIC) United States $0.078B 0.00
Nephros (NEPH) United States $0.077B 0.00
FSD PHARMA INC (HUGE) $0.049B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
GUARDION HEALTH (GHSI) United States $0.024B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00